1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Migratory CD103+CD11b+ cDC2 cells in Peyer's patches are critical for gut IgA responses following oral immunization.
- Contribution to journal › Article
- 2022
-
Mark
Peyer's patch T
H17 cells are dispensable for gut IgA responses to oral immunization.
- Contribution to journal › Article
-
Mark
Clonotypic analysis of protective influenza M2e-specific lung resident Th17 memory cells reveals extensive functional diversity
- Contribution to journal › Article
-
Mark
ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection
- Contribution to journal › Article
- 2021
-
Mark
A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection
- Contribution to journal › Article
-
Mark
Single-cell BCR and transcriptome analysis after influenza infection reveals spatiotemporal dynamics of antigen-specific B cells
- Contribution to journal › Article
- 2020
-
Mark
The CTA1-DD adjuvant strongly potentiates follicular dendritic cell function and germinal center formation, which results in improved neonatal immunization
- Contribution to journal › Article
- 2019
-
Mark
Class-switch recombination to IgA in the Peyer's patches requires natural thymus-derived Tregs and appears to be antigen independent
- Contribution to journal › Article
-
Mark
Class-switch recombination to IgA in the Peyer’s patches requires natural thymus-derived Tregs and appears to be antigen independent
- Contribution to journal › Article
-
Mark
Activated Peyer′s patch B cells sample antigen directly from M cells in the subepithelial dome
- Contribution to journal › Article
